Reply to Dr Hawkins regarding comparability of results for monitoring

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Home pregnancy tests: quality first
4. Review
5. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders
6. Opinion Papers
7. Basophil counting in hematology analyzers: time to discontinue?
8. The role of laboratory hematology between technology and professionalism: the paradigm of basophil counting
9. Recommendations for validation testing of home pregnancy tests (HPTs) in Europe
10. General Clinical Chemistry and Laboratory Medicine
11. The use of preanalytical quality indicators: a Turkish preliminary survey study
12. The Italian External Quality Assessment (EQA) program on urinary sediment by microscopy examination: a 20 years journey
13. Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
14. Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor
15. Impact of routine S100B protein assay on CT scan use in children with mild traumatic brain injury
16. Using machine learning to develop an autoverification system in a clinical biochemistry laboratory
17. Effect of collection matrix, platelet depletion, and storage conditions on plasma extracellular vesicles and extracellular vesicle-associated miRNAs measurements
18. Pneumatic tube transportation of urine samples
19. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine
20. A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane–tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies
21. Immunosuppressant quantification in intravenous microdialysate – towards novel quasi-continuous therapeutic drug monitoring in transplanted patients
22. Reference Values and Biological Variations
23. Reference intervals for venous blood gas measurement in adults
24. Cardiovascular Diseases
25. Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy
26. Diabetes
27. Evaluation of the ARKRAY HA-8190V instrument for HbA_1c
28. Infectious Diseases
29. An original multiplex method to assess five different SARS-CoV-2 antibodies
30. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs
31. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR
32. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study
33. Corrigenda
34. Corrigendum to: Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals
35. Corrigendum to: Age appropriate reference intervals for eight kidney function and injury markers in infants, children and adolescents
36. Letters to the Editor
37. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers
38. Letter in reply to the letter to the editor of Harte JV and Mykytiv V with the title “A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data”
39. SARS-CoV-2 serologic tests: do not forget the good laboratory practice
40. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients
41. Self-sampling at home using volumetric absorptive microsampling: coupling analytical evaluation to volunteers’ perception in the context of a large scale study
42. Vortex mixing to alleviate pseudothrombocytopenia in a blood specimen with platelet satellitism and platelet clumps
43. Comparative evaluation of the fully automated HemosIL^® AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13
44. Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients
45. As time goes by, on that you can rely … preservation of urine samples for morphological analysis of erythrocytes and casts
46. Stability of control materials for α-thalassemia immunochromatographic strip test
47. Reformulated Architect^® cyclosporine CMIA assay: improved imprecision, worse comparability between methods
48. Urine-to-plasma contamination mimicking acute kidney injury: small drops with major consequences
49. Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism
50. Use of common reference intervals does not necessarily allow inter-method numerical result trending
51. Reply to Dr Hawkins regarding comparability of results for monitoring